site stats

Phesgo drug class

WebAug 9, 2024 · Drug Class: Targeted Therapy Medications. Company: Genentech. Approval Status: Approved. Generic Version Available: No. Drug Indication. Phesgo is an injectable fixed-dose combination regimen containing pertuzumab, trastuzumab and hyaluronidase that can be administered by a health care provider at home. It is approved for people with … Web7 DRUG INTERACTIONS 8 USE IN SPECIFIC POPULATIONS . 8.1 . Pregnancy 8.2 . Lactation 8.3 . Females and Males of Reproductive Potential 8.4 . Pediatric Use 8.5 . Geriatric Use. ... PHESGO must always be administered by a healthcare professional. In patients receiving an anthracycline- based regimen for early breast cancer, administer

PHESGO Prescribing Information - Genentech

WebIf Phesgo is administered during pregnancy, or if a patient becomes pregnant while receiving Phesgo or within 7 mo following last dose of Phesgo , health care providers and patients should immediately report Phesgo exposure to pharmacovigilance program at Genentech at 1-888-835-2555. WebInjection time. The first dose of PHESGO takes about 8 minutes to inject. Other doses take about 5 minutes to inject. Your healthcare team will wait at least 30 minutes after the first dose, and at least 15 minutes after each following dose, to check for any reactions. If side effects occur, your healthcare provider may slow, delay, or stop ... season 1 the mandalorian https://karenmcdougall.com

HER2-Positive Breast Cancer Treatment PHESGO® (pertuzumab ...

WebJul 10, 2024 · Phesgo (Hyaluronidase Pertuzumab and Trastuzumab) Generic Name: Hyaluronidase, pertuzumab, and trastuzumab Reviewed: July 10, 2024 Hyaluronidase, pertuzumab, and trastuzumab is a combination... WebThis product contains 3 ingredients: pertuzumab, trastuzumab, and hyaluronidase. It is used to treat a certain type of breast cancer. The cancer cells make more than the usual amount of a certain... WebApr 14, 2024 · Phesgo will be given to you by a doctor or nurse at a hospital or clinic. Phesgo is given as an injection under the skin ( subcutaneous injection ). The injection will be given every three weeks. You will receive an injection first in one thigh than in the other. season 1 the rookie

NDC 50242-260 Phesgo Injection, Solution Subcutaneous

Category:PHESGO® (pertuzumab / trastuzumab / hyaluronidase …

Tags:Phesgo drug class

Phesgo drug class

NDC 50242-260 Phesgo Label Information

WebPHESGO ™ is a prescription medicine approved for use in combination with docetaxel in adults who have HER2-positive breast cancer that has spread to different parts of the … WebView Phesgo mechanism of action for pharmacodynamics and pharmacokinetics details. MIMS Class Targeted Cancer Therapy ATC Classification L01XY02 - pertuzumab and trastuzumab ; Belongs to the class of combinations of antineoplastic agents. Used in the treatment of cancer. Regulatory Classification B Presentation/Packing Form

Phesgo drug class

Did you know?

WebOct 13, 2024 · Phesgo (pertuzumab, trastuzumab, and hyaluronidase-zzxf) is a combination of HER2 /neu receptor antagonists and an endoglycosidase indicated for use in … WebAug 8, 2024 · Phesgo contains a combination of hyaluronidase, pertuzumab, and trastuzumabis. Phesgo is a cancer medicine that is used alone or with other medicines to treat early-stage breast cancer. Phesgo is also used to treat HER2-positive breast cancer … Phesgo is indicated for use in combination with docetaxel for the treatment of adult …

WebPhesgo is a human prescription drug by Genentech, Inc.. The product is distributed in 2 packages with NDC codes 50242-260-01, 50242-260-86.PHESGO is contraindi. Search. Home; ... A pharmacologic class is a group of drugs that share the same scientifically documented properties. The following is a list of the reported pharmacologic class(es ... WebDRUG INTERACTIONS 8 USE IN SPECIFIC POPULATIONS 8.1 Pregnancy 8.2 Lactation 8.3 Females and Males of Reproductive Potential 8.4 Pediatric Use 8.5 Geriatric Use 11 ...

WebPHESGO administration can result in subclinical and clinical cardiac failure. The incidence and severity was highest in patients receiving PHESGO with anthracycline-containing chemotherapy regimens. ... (NYHA Class III/IV) with a LVEF decline ≥ 10% and a drop to less than 50% was 0.8% in the PHESGO arm. ... Parenteral drug products should be ... WebSep 30, 2024 · The U.S. Food and Drug Administration (FDA) has approved trastuzumab, pertuzumab, and trastuzumab + pertuzumab subcutaneous fixed dose combination (PHESGO) as treatment for HER2 positive breast cancer. The FDA has also approved hormonal therapies as treatment for hormone receptor positive breast cancer. . Study …

WebPhesgo has different dosage and administration instructions than IV pertuzumab, IV trastuzumab, and SC trastuzumab when administered alone ... Adding plans allows you to …

WebMar 19, 2008 · Perjeta, Perjeta-Herceptin, Phesgo Generic Name Pertuzumab DrugBank Accession Number DB06366 Background Pertuzumab is a recombinant humanized monoclonal antibody that targets the extracellular dimerization domain (subdomain II) of the human epidermal growth factor receptor 2 protein (HER2). season 1 the loud houseWebMar 18, 2024 · Phesgo 600 mg/600 mg solution for injection Active Ingredient: trastuzumab, pertuzumab Company: Roche Products Limited See contact details ATC code: L01XY02 About Medicine Prescription only medicine Healthcare Professionals (SmPC) Patient Leaflet (PIL) This information is for use by healthcare professionals Last updated on emc: 18 Mar … season 1 the rap gameWebMar 1, 2024 · • you have ever had chemotherapy medicine from the class called anthracycline, e.g. doxorubicin – these medicines can damage heart muscle and increase the risk of heart problems with PHESGO; • you have ever had radiotherapy to the chest area prior to treatment with PHESGO as it can increase the risk of heart problems; or season 1 the school in the sky